AQR Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$239K Buy
35,620
+4,701
+15% +$31.6K ﹤0.01% 2968
2025
Q1
$280K Sell
30,919
-24,060
-44% -$218K ﹤0.01% 2722
2024
Q4
$951K Buy
54,979
+15,511
+39% +$268K ﹤0.01% 1911
2024
Q3
$631K Buy
+39,468
New +$631K ﹤0.01% 2066